Artificial intelligence and machine learning in precision and genomic medicine Sameer Quazi Review Article 15 June 2022 Article: 120
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) Giulio FrancoliniMauro LoiLorenzo Livi Original Paper 10 June 2022 Article: 119
Pentacyclic triterpenoid ursolic acid induces apoptosis with mitochondrial dysfunction in adult T-cell leukemia MT-4 cells to promote surrounding cell growth Mengyue ShenDuo WangYasuhiro Yoshida Original Paper 08 June 2022 Article: 118
S100A8 inhibition in leukemic lymphoblasts induces sensitivity to chemotherapy and inhibition of disease relapse Mohamad Javad HejaziGholamhossein TamaddonMohammadreza Sharifi Original Paper 08 June 2022 Article: 117
Antiproliferative and cytotoxic effects of bioactive compounds isolated from Onosma bourgaei Ramazan ErenlerIlyas YildizNusret Genc Original Paper 08 June 2022 Article: 116
Therapeutic effect of some natural active compounds for breast cancer Faik Gökalp Original Paper 08 June 2022 Article: 115
The effect of mesenchymal stromal cells ın the microenvironment on cancer development Özlem Sağlam-Uçarİrfan DeğirmenciN. Zafer Utkan Original Paper 08 June 2022 Article: 114
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) Isacco DesideriSara LucidiLorenzo Livi Original Paper 06 June 2022 Article: 113
The anti-ovarian carcinoma activity of l-amino acid oxidase from Crotalus adamanteus venom in vivo and in vitro Yan XiongQiyi HeZiwei Song Original Paper 06 June 2022 Article: 112
UHRF1 modulates breast cancer cell growth via estrogen signaling Guosheng LuoQuanhui LiJianghua Lai Original Paper 06 June 2022 Article: 111
Effect of concomitant use of G-CSF and myelosuppressive chemotherapy on bone marrow and peripheral granulocytes in a mouse model Yuki EndoTakeshi IshikawaYoshito Itoh Original Paper 06 June 2022 Article: 110
Stereotactic body radiotherapy for spinal metastases: a review Lanlan GuoLixin KeLixia Lu Review Article 23 May 2022 Article: 103
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen Farshid DayyaniKit TamMay T. Cho Original Paper 23 May 2022 Article: 102
Synergistic antitumor effect of Andrographolide and cisplatin through ROS-mediated ER stress and STAT3 inhibition in colon cancer Huang HongWeilan CaoChongjie Huang Original Paper 23 May 2022 Article: 101
Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation Aneesha PolisetyGauri MisraAnant Narayan Bhatt Original Paper 23 May 2022 Article: 100
In vitro antiproliferative and cytotoxic activities of novel triphenyltin isoselenocyanate in human breast carcinoma cell lines MCF 7 and MDA-MB-231 Luba HunakovaEva HorvathovaJulius Brtko Original Paper 23 May 2022 Article: 99
The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells Nihal BirdenNur Selvi GunelCigir Biray Avci Original Paper 23 May 2022 Article: 98
Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms Maira da Costa CacemiroJuçara Gastaldi CominalFabíola Attié de Castro Original Paper 23 May 2022 Article: 97
Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis Baijun DongBin YangWei Xue Original Paper 23 May 2022 Article: 96
